Advances in minimally invasive cardiac surgery for the treatment of valvular diseases_Chinese Journal of Clinical Thoracic and Cardiovascular Surgery

Authors：

WANG Qing ¹ , LIU Mei ¹ , LI Hanluo ¹ ,  SHANG Xiaoke ^1,2

1. Laboratory of Cardiac Dynamics and Assistive Technology, School of Life Sciences and Health Engineering, Hubei University of Technology, Wuhan, 430068, P. R. China;
2. Department of Cardiovascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, P. R. China;

Corresponding?author：

SHANG Xiaoke, Email: sxs_sxk@163.com

Keywords：

Minimally invasive; cardiac surgery; valvular disease; review

DOI：

10.7507/1007-4848.202412101

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

With the continuous innovation in medical technology, the field of cardiac surgery has witnessed significant technological breakthroughs, particularly in the innovative application of minimally invasive techniques in the treatment of valvular diseases. Minimally invasive cardiac surgery addresses valve diseases such as tricuspid valve, mitral valve, and aortic valve, encompassing various surgical techniques including small incisions, thoracoscopy, and robotics. Compared to traditional thoracotomy, minimally invasive techniques exhibit notable clinical advantages, characterized by minimized surgical incisions, reduced postoperative pain, decreased perioperative complication rates, shortened hospital stays, and accelerated recovery of body functions. Driven by the precision development of surgical instruments, the collaborative advancement of imaging and perioperative monitoring technologies, and the gradual improvement of standardized training systems for specialist physicians, minimally invasive cardiac surgery techniques continue to innovate and evolve rapidly. This article aims to systematically elaborate on the latest research progress of minimally invasive cardiac surgery techniques in the treatment of valvular diseases.

Citation： WANG Qing, LIU Mei, LI Hanluo, SHANG Xiaoke. Advances in minimally invasive cardiac surgery for the treatment of valvular diseases. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2025, 32(9): 1328-1333. doi: 10.7507/1007-4848.202412101 Copy

1.	Rainer WG. Cardiac surgery before cardiopulmonary bypass. Perfusion, 2003, 18(3): 139-144.
2.	Chen J, Wei L, Wang C. The impact of minimally invasive technique on the outcomes of isolated tricuspid valve surgery. Eur Heart J, 2021, 42(19): 1926.
3.	Ha B, Usman AA, Augoustides JG. Minimally invasive cardiac surgery-identifying opportunities for further improvement in the quality of postoperative patient recovery. J Cardiothorac Vasc Anesth, 2020, 34(12): 3231-3233.
4.	Davidson LJ, Davidson CJ. Transcatheter treatment of valvular heart disease: a review. JAMA, 2021, 325(24): 2480-2494.
5.	Kirmani BH, Knowles A, Saravanan P, et al. Establishing minimally invasive cardiac surgery in a low-volume mitral surgery centre. Ann R Coll Surg Engl, 2021, 103(6): 444-451.
6.	De Viti D, Dambruoso P, Izzo P, et al. Iatrogenic acute aortic dissection in the era of minimally invasive cardiac surgery: experience of a center and review of literature. Braz J Cardiovasc Surg, 2021, 36(5): 691-699.
7.	Dreyfus G, Windecker S. How to shape the future of cardiology and cardiac surgery? Eur Heart J, 2020, 41(38): 3693-3701.
8.	Gaudino M, Benesch C, Bakaeen F, et al. Considerations for reduction of risk of perioperative stroke in adult patients undergoing cardiac and thoracic aortic operations: a scientific statement from the American Heart Association. Circulation, 2020, 142(14): e193-e209.
9.	Lee SH, Yoon SJ, Sun BJ, et al. 2023 Korean Society of Echocardiography position paper for diagnosis and management of valvular heart disease, partⅠ: aortic valve disease. J Cardiovasc Imaging, 2024, 32(1): 34.
10.	Coisne A, Lancellotti P, Habib G, et al. ACC/AHA and ESC/EACTS guidelines for the management of valvular heart diseases: JACC guideline comparison. J Am Coll Cardiol, 2023, 82(16): 1648.
11.	Zhu J, Zhang Y, Bao C, et al. Individualized strategy of minimally invasive cardiac surgery in congenital cardiac septal defects. J Cardiothorac Surg, 2022, 17(1): 5.
12.	Qureshi SH, Ruel M. The 7 pillars of multivessel minimally invasive coronary surgery. Innovations (Phila), 2021, 16(3): 216-217.
13.	Karsan RB, Allen R, Powell A, et al. Minimally-invasive cardiac surgery: a bibliometric analysis of impact and force to identify key and facilitating advanced training. J Cardiothorac Surg, 2022, 17(1): 236.
14.	Lyons M, Akowuah E, Hunter S, et al. A survey of minimally invasive cardiac surgery during the COVID-19 pandemic. Perfusion, 2022, 37(8): 789-796.
15.	Mortada H, Alsuhaim A, Alkhamees N, et al. Periareolar minimally invasive approach for cardiac surgery: a case series and description of technique with a review of literature. J Cardiothorac Surg, 2024, 19(1): 477.
16.	Condello I, Santarpino G, Moscarelli M, et al. Toward minimally invasive extracorporeal circulation in oncologic cardiac surgery. Braz J Cardiovasc Surg, 2021, 36(1): 141-142.
17.	Gaudino M, Chikwe J, Bagiella E, et al. Methodological standards for the design, implementation, and analysis of randomized trials in cardiac surgery: a scientific statement from the American Heart Association. Circulation, 2022, 145(4): e129-e142.
18.	Olsthoorn JR, Heuts S, Houterman S, et al. Minimally invasive approach compared to resternotomy for mitral valve surgery in patients with prior cardiac surgery: retrospective multicentre study based on the Netherlands Heart Registration. Eur J Cardiothorac Surg, 2022, 62(5): ezac420.
19.	Sabatino ME, Okoh AK, Chao JC, et al. Early discharge after minimally invasive aortic and mitral valve surgery. Ann Thorac Surg, 2022, 114(1): 91-97.
20.	Huang W, Hou B, Li Q, et al. Comparative efficacy of five surgical methods in the treatment of mitral regurgitation: a systematic review and network meta-analysis. J Card Surg, 2022, 37(1): 186-196.
21.	李娟, 蔡慶慧, 李少珂, 等. 3D全胸腔鏡在再次心臟瓣膜手術中的應用效果及術后ARI影響因素分析. 中西醫結合心腦血管病雜志, 2024, 22(9): 1662-1665.Li J, Cai QH, Li SK, et al. Application effect of 3D total thoracoscopy in redo cardiac valve surgery and analysis of influencing factors of postoperative ARI. Chin J Integr Med Cardio-Cerebrovasc Dis, 2024, 22(9): 1662-1665.
22.	Akowuah EF, Maier RH, Hancock HC, et al. Minithoracotomy vs conventional sternotomy for mitral valve repair: a randomized clinical trial. JAMA, 2023, 329(22): 1957-1966.
23.	Tang S, Qu Y, Jiang H, et al. Minimally invasive technique facilitates early extubation after cardiac surgery: a single-center retrospective study. BMC Anesthesiol, 2024, 24(1): 318.
24.	Rodriguez E, Nifong LW, Bonatti J, et al. Pathway for surgeons and programs to establish and maintain a successful robot-assisted adult cardiac surgery program. Ann Thorac Surg, 2016, 102(1): 340-344.
25.	Behinaein P, Antonoff MB. Innovation in cardiothoracic surgery: a team-based recipe for success. J Thorac Cardiovasc Surg, 2023, 166(3): e124-e125.
26.	Badhwar V, Wei LM, Geirsson A, et al. Contemporary robotic cardiac surgical training. J Thorac Cardiovasc Surg, 2023, 165(2): 779-783.
27.	Kleiman NS, Welt FGP, Truesdell AG, et al. Should interventional cardiologists super-specialize? Moving from patient selection to operator selection. JACC Cardiovasc Interv, 2021, 14(1): 97-100.
28.	Agricola E, Ancona F, Bartel T, et al. Multimodality imaging for patient selection, procedural guidance, and follow-up of transcatheter interventions for structural heart disease: a consensus document of the EACVI Task Force on Interventional Cardiovascular Imaging: part 1: access routes, transcatheter aortic valve implantation, and transcatheter mitral valve interventions. Eur Heart J Cardiovasc Imaging, 2023, 24(9): e209-e268.
29.	Zoghbi WA, Jone PN, Chamsi-Pasha MA, et al. Guidelines for the evaluation of prosthetic valve function with cardiovascular imaging: a report from the American Society of Echocardiography developed in collaboration with the Society for Cardiovascular Magnetic Resonance and the Society of Cardiovascular Computed Tomography. J Am Soc Echocardiogr, 2024, 37(1): 2-63.
30.	Baumbach A, Patel KP, Kennon S, et al. A heart valve dedicated for aortic regurgitation: review of technology and early clinical experience with the transfemoral Trilogy system. Catheter Cardiovasc Interv, 2023, 102(4): 766-771.
31.	Kronenberg F. Aortic valve stenosis: the long and winding road. Eur Heart J, 2021, 42(22): 2212-2214.
32.	Landmesser U. The changing landscape of aortic-valve stenosis management. N Engl J Med, 2023, 389(21): 2008-2009.
33.	Borger MA, Raschpichler M, Makkar R. Repeat aortic valve surgery or transcatheter valve-in-valve therapy: we need a randomized trial. J Am Coll Cardiol, 2020, 76(5): 500-502.
34.	中國醫師協會心血管內科醫師分會結構性心臟病學組, 亞太結構性心臟病俱樂部. 中國經導管主動脈瓣置換術臨床路徑專家共識(2024版). 中國胸心血管外科臨床雜志, 2024, 31(12): 1713-1727.Structural Heart Disease Group of Cardiovascular Physician Branch of Chinese Medical Doctor Association, Asia-Pacific Structural Heart Disease Club. Expert consensus on clinical pathway for transcatheter aortic valve replacement in China (2024 edition). Chin J Clin Thorac Cardiovasc Surg, 2024, 31(12): 1713-1727.
35.	Gillinov M, Burns DJP, Wierup P. Commentary: mitral valve repair wins again. J Thorac Cardiovasc Surg, 2021, 162(1): 83.
36.	Chen J, Yang Y, Wei L. One-stage transcatheter aortic valve replacement and transcatheter edge-to-edge repair for aortic and mitral regurgitation. Eur Heart J, 2023, 44(15): 1377.
37.	Adamo M, Metra M, Alfieri O. Percutaneous valve repair of functional mitral regurgitation: aiming at optimal and durable results. Eur J Heart Fail, 2020, 22(10): 1849-1851.
38.	Pojar M, Karalko M, Dergel M, et al. Minimally invasive or sternotomy approach in mitral valve surgery: a propensity-matched comparison. J Cardiothorac Surg, 2021, 16(1): 228.
39.	亞太心臟病學會(APSC)專家組. 經導管緣對緣技術(MitraClip)治療二尖瓣反流—亞太心臟病學會(APSC)專家共識. 中國循環雜志, 2022, 37(1): 4-11.Asia-Pacific Society of Cardiology (APSC) Expert Group. Transcatheter edge-to-edge repair (MitraClip) for mitral regurgitation: expert consensus of the Asia-Pacific Society of Cardiology (APSC). Chin Circ J, 2022, 37(1): 4-11.
40.	Sticchi A, Reineke D, Praz F, et al. Transcatheter mitral valve replacement for mitral valve-in-valve, valve-in-ring, and valve-in-MAC using balloon-expandable transcatheter heart valves. JACC Cardiovasc Interv, 2021, 14(8): 873-878.
41.	Rodés-Cabau J, Regueiro A, Mack MJ. Transcatheter mitral valve replacement: a need for better patient selection. J Am Coll Cardiol, 2021, 78(19): 1860-1862.
42.	Zhang QL, Chen Q, Lin ZQ, et al. Thoracoscope-assisted mitral valve replacement with a small incision in the right chest: a Chinese single cardiac center experience. Med Sci Monit, 2018, 24: 1054-1063.
43.	Wild MG, Praz F. Caval valve implantation for advanced tricuspid regurgitation: closing a therapeutic gap? JACC Cardiovasc Interv, 2022, 15(13): 1378-1381.
44.	Maisano F, Hahn R, Sorajja P, et al. Transcatheter treatment of the tricuspid valve: current status and perspectives. Eur Heart J, 2024, 45(11): 876-894.
45.	Lurz P, Kresoja KP. Tricuspid valve therapies: closing the gap. JACC Cardiovasc Interv, 2021, 14(11): 1241-1242.
46.	中國醫師協會心血管內科醫師分會結構性心臟病學組, 蘇州工業園區東方華夏心血管健康研究院. 三尖瓣反流經導管治療的中國專家共識. 中國介入心臟病學雜志, 2024, 32(10): 551-561.Structural Heart Disease Group of Cardiovascular Physician Branch of Chinese Medical Doctor Association, Suzhou Industrial Park Oriental Cathay Cardiovascular Health Institute. Chinese expert consensus on transcatheter treatment of tricuspid regurgitation. Chin J Interv Cardiol, 2024, 32(10): 551-561.
47.	Latib A, Ho EC. Tricuspid valve morphology in transcatheter interventions: worth a closer look. JACC Cardiovasc Interv, 2021, 14(20): 2271-2273.
48.	Davidson LJ, Tang GHL, Ho EC, et al. The tricuspid valve: a review of pathology, imaging, and current treatment options: a scientific statement from the American Heart Association. Circulation, 2024, 149(22): e1223-e1238.
49.	Hascoet S, Karsenty C, Fraisse A. Transcatheter pulmonary valve replacement: history is on the move. JACC Cardiovasc Interv, 2024, 17(2): 245-247.
50.	Rhodes JF Jr, Veeraswamy R. Expanding transcatheter pulmonary valve therapies. JACC Cardiovasc Interv, 2020, 13(23): 2766-2768.
51.	中國醫師協會心血管內科醫師分會結構性心臟病學組, 亞洲心臟病學會, 國家放射與治療臨床醫學研究中心. 經導管肺動脈瓣置換術亞洲專家共識. 中國介入心臟病學雜志, 2023, 31(6): 404-412.Structural Heart Disease Group of Cardiovascular Physician Branch of Chinese Medical Doctor Association, Asian Society of Cardiology, National Clinical Research Center for Interventional Medicine. Asian expert consensus on transcatheter pulmonary valve replacement. Chin J Interv Cardiol, 2023, 31(6): 404-412.
52.	Tannous P, Nugent A. Transcatheter pulmonary valve replacement in native and nonconduit right ventricle outflow tracts. J Thorac Cardiovasc Surg, 2021, 162(3): 967-970.

1. Rainer WG. Cardiac surgery before cardiopulmonary bypass. Perfusion, 2003, 18(3): 139-144.
2. Chen J, Wei L, Wang C. The impact of minimally invasive technique on the outcomes of isolated tricuspid valve surgery. Eur Heart J, 2021, 42(19): 1926.
3. Ha B, Usman AA, Augoustides JG. Minimally invasive cardiac surgery-identifying opportunities for further improvement in the quality of postoperative patient recovery. J Cardiothorac Vasc Anesth, 2020, 34(12): 3231-3233.
4. Davidson LJ, Davidson CJ. Transcatheter treatment of valvular heart disease: a review. JAMA, 2021, 325(24): 2480-2494.
5. Kirmani BH, Knowles A, Saravanan P, et al. Establishing minimally invasive cardiac surgery in a low-volume mitral surgery centre. Ann R Coll Surg Engl, 2021, 103(6): 444-451.
6. De Viti D, Dambruoso P, Izzo P, et al. Iatrogenic acute aortic dissection in the era of minimally invasive cardiac surgery: experience of a center and review of literature. Braz J Cardiovasc Surg, 2021, 36(5): 691-699.
7. Dreyfus G, Windecker S. How to shape the future of cardiology and cardiac surgery? Eur Heart J, 2020, 41(38): 3693-3701.
8. Gaudino M, Benesch C, Bakaeen F, et al. Considerations for reduction of risk of perioperative stroke in adult patients undergoing cardiac and thoracic aortic operations: a scientific statement from the American Heart Association. Circulation, 2020, 142(14): e193-e209.
9. Lee SH, Yoon SJ, Sun BJ, et al. 2023 Korean Society of Echocardiography position paper for diagnosis and management of valvular heart disease, partⅠ: aortic valve disease. J Cardiovasc Imaging, 2024, 32(1): 34.
10. Coisne A, Lancellotti P, Habib G, et al. ACC/AHA and ESC/EACTS guidelines for the management of valvular heart diseases: JACC guideline comparison. J Am Coll Cardiol, 2023, 82(16): 1648.
11. Zhu J, Zhang Y, Bao C, et al. Individualized strategy of minimally invasive cardiac surgery in congenital cardiac septal defects. J Cardiothorac Surg, 2022, 17(1): 5.
12. Qureshi SH, Ruel M. The 7 pillars of multivessel minimally invasive coronary surgery. Innovations (Phila), 2021, 16(3): 216-217.
13. Karsan RB, Allen R, Powell A, et al. Minimally-invasive cardiac surgery: a bibliometric analysis of impact and force to identify key and facilitating advanced training. J Cardiothorac Surg, 2022, 17(1): 236.
14. Lyons M, Akowuah E, Hunter S, et al. A survey of minimally invasive cardiac surgery during the COVID-19 pandemic. Perfusion, 2022, 37(8): 789-796.
15. Mortada H, Alsuhaim A, Alkhamees N, et al. Periareolar minimally invasive approach for cardiac surgery: a case series and description of technique with a review of literature. J Cardiothorac Surg, 2024, 19(1): 477.
16. Condello I, Santarpino G, Moscarelli M, et al. Toward minimally invasive extracorporeal circulation in oncologic cardiac surgery. Braz J Cardiovasc Surg, 2021, 36(1): 141-142.
17. Gaudino M, Chikwe J, Bagiella E, et al. Methodological standards for the design, implementation, and analysis of randomized trials in cardiac surgery: a scientific statement from the American Heart Association. Circulation, 2022, 145(4): e129-e142.
18. Olsthoorn JR, Heuts S, Houterman S, et al. Minimally invasive approach compared to resternotomy for mitral valve surgery in patients with prior cardiac surgery: retrospective multicentre study based on the Netherlands Heart Registration. Eur J Cardiothorac Surg, 2022, 62(5): ezac420.
19. Sabatino ME, Okoh AK, Chao JC, et al. Early discharge after minimally invasive aortic and mitral valve surgery. Ann Thorac Surg, 2022, 114(1): 91-97.
20. Huang W, Hou B, Li Q, et al. Comparative efficacy of five surgical methods in the treatment of mitral regurgitation: a systematic review and network meta-analysis. J Card Surg, 2022, 37(1): 186-196.
21. 李娟, 蔡慶慧, 李少珂, 等. 3D全胸腔鏡在再次心臟瓣膜手術中的應用效果及術后ARI影響因素分析. 中西醫結合心腦血管病雜志, 2024, 22(9): 1662-1665.Li J, Cai QH, Li SK, et al. Application effect of 3D total thoracoscopy in redo cardiac valve surgery and analysis of influencing factors of postoperative ARI. Chin J Integr Med Cardio-Cerebrovasc Dis, 2024, 22(9): 1662-1665.
22. Akowuah EF, Maier RH, Hancock HC, et al. Minithoracotomy vs conventional sternotomy for mitral valve repair: a randomized clinical trial. JAMA, 2023, 329(22): 1957-1966.
23. Tang S, Qu Y, Jiang H, et al. Minimally invasive technique facilitates early extubation after cardiac surgery: a single-center retrospective study. BMC Anesthesiol, 2024, 24(1): 318.
24. Rodriguez E, Nifong LW, Bonatti J, et al. Pathway for surgeons and programs to establish and maintain a successful robot-assisted adult cardiac surgery program. Ann Thorac Surg, 2016, 102(1): 340-344.
25. Behinaein P, Antonoff MB. Innovation in cardiothoracic surgery: a team-based recipe for success. J Thorac Cardiovasc Surg, 2023, 166(3): e124-e125.
26. Badhwar V, Wei LM, Geirsson A, et al. Contemporary robotic cardiac surgical training. J Thorac Cardiovasc Surg, 2023, 165(2): 779-783.
27. Kleiman NS, Welt FGP, Truesdell AG, et al. Should interventional cardiologists super-specialize? Moving from patient selection to operator selection. JACC Cardiovasc Interv, 2021, 14(1): 97-100.
28. Agricola E, Ancona F, Bartel T, et al. Multimodality imaging for patient selection, procedural guidance, and follow-up of transcatheter interventions for structural heart disease: a consensus document of the EACVI Task Force on Interventional Cardiovascular Imaging: part 1: access routes, transcatheter aortic valve implantation, and transcatheter mitral valve interventions. Eur Heart J Cardiovasc Imaging, 2023, 24(9): e209-e268.
29. Zoghbi WA, Jone PN, Chamsi-Pasha MA, et al. Guidelines for the evaluation of prosthetic valve function with cardiovascular imaging: a report from the American Society of Echocardiography developed in collaboration with the Society for Cardiovascular Magnetic Resonance and the Society of Cardiovascular Computed Tomography. J Am Soc Echocardiogr, 2024, 37(1): 2-63.
30. Baumbach A, Patel KP, Kennon S, et al. A heart valve dedicated for aortic regurgitation: review of technology and early clinical experience with the transfemoral Trilogy system. Catheter Cardiovasc Interv, 2023, 102(4): 766-771.
31. Kronenberg F. Aortic valve stenosis: the long and winding road. Eur Heart J, 2021, 42(22): 2212-2214.
32. Landmesser U. The changing landscape of aortic-valve stenosis management. N Engl J Med, 2023, 389(21): 2008-2009.
33. Borger MA, Raschpichler M, Makkar R. Repeat aortic valve surgery or transcatheter valve-in-valve therapy: we need a randomized trial. J Am Coll Cardiol, 2020, 76(5): 500-502.
34. 中國醫師協會心血管內科醫師分會結構性心臟病學組, 亞太結構性心臟病俱樂部. 中國經導管主動脈瓣置換術臨床路徑專家共識(2024版). 中國胸心血管外科臨床雜志, 2024, 31(12): 1713-1727.Structural Heart Disease Group of Cardiovascular Physician Branch of Chinese Medical Doctor Association, Asia-Pacific Structural Heart Disease Club. Expert consensus on clinical pathway for transcatheter aortic valve replacement in China (2024 edition). Chin J Clin Thorac Cardiovasc Surg, 2024, 31(12): 1713-1727.
35. Gillinov M, Burns DJP, Wierup P. Commentary: mitral valve repair wins again. J Thorac Cardiovasc Surg, 2021, 162(1): 83.
36. Chen J, Yang Y, Wei L. One-stage transcatheter aortic valve replacement and transcatheter edge-to-edge repair for aortic and mitral regurgitation. Eur Heart J, 2023, 44(15): 1377.
37. Adamo M, Metra M, Alfieri O. Percutaneous valve repair of functional mitral regurgitation: aiming at optimal and durable results. Eur J Heart Fail, 2020, 22(10): 1849-1851.
38. Pojar M, Karalko M, Dergel M, et al. Minimally invasive or sternotomy approach in mitral valve surgery: a propensity-matched comparison. J Cardiothorac Surg, 2021, 16(1): 228.
39. 亞太心臟病學會(APSC)專家組. 經導管緣對緣技術(MitraClip)治療二尖瓣反流—亞太心臟病學會(APSC)專家共識. 中國循環雜志, 2022, 37(1): 4-11.Asia-Pacific Society of Cardiology (APSC) Expert Group. Transcatheter edge-to-edge repair (MitraClip) for mitral regurgitation: expert consensus of the Asia-Pacific Society of Cardiology (APSC). Chin Circ J, 2022, 37(1): 4-11.
40. Sticchi A, Reineke D, Praz F, et al. Transcatheter mitral valve replacement for mitral valve-in-valve, valve-in-ring, and valve-in-MAC using balloon-expandable transcatheter heart valves. JACC Cardiovasc Interv, 2021, 14(8): 873-878.
41. Rodés-Cabau J, Regueiro A, Mack MJ. Transcatheter mitral valve replacement: a need for better patient selection. J Am Coll Cardiol, 2021, 78(19): 1860-1862.
42. Zhang QL, Chen Q, Lin ZQ, et al. Thoracoscope-assisted mitral valve replacement with a small incision in the right chest: a Chinese single cardiac center experience. Med Sci Monit, 2018, 24: 1054-1063.
43. Wild MG, Praz F. Caval valve implantation for advanced tricuspid regurgitation: closing a therapeutic gap? JACC Cardiovasc Interv, 2022, 15(13): 1378-1381.
44. Maisano F, Hahn R, Sorajja P, et al. Transcatheter treatment of the tricuspid valve: current status and perspectives. Eur Heart J, 2024, 45(11): 876-894.
45. Lurz P, Kresoja KP. Tricuspid valve therapies: closing the gap. JACC Cardiovasc Interv, 2021, 14(11): 1241-1242.
46. 中國醫師協會心血管內科醫師分會結構性心臟病學組, 蘇州工業園區東方華夏心血管健康研究院. 三尖瓣反流經導管治療的中國專家共識. 中國介入心臟病學雜志, 2024, 32(10): 551-561.Structural Heart Disease Group of Cardiovascular Physician Branch of Chinese Medical Doctor Association, Suzhou Industrial Park Oriental Cathay Cardiovascular Health Institute. Chinese expert consensus on transcatheter treatment of tricuspid regurgitation. Chin J Interv Cardiol, 2024, 32(10): 551-561.
47. Latib A, Ho EC. Tricuspid valve morphology in transcatheter interventions: worth a closer look. JACC Cardiovasc Interv, 2021, 14(20): 2271-2273.
48. Davidson LJ, Tang GHL, Ho EC, et al. The tricuspid valve: a review of pathology, imaging, and current treatment options: a scientific statement from the American Heart Association. Circulation, 2024, 149(22): e1223-e1238.
49. Hascoet S, Karsenty C, Fraisse A. Transcatheter pulmonary valve replacement: history is on the move. JACC Cardiovasc Interv, 2024, 17(2): 245-247.
50. Rhodes JF Jr, Veeraswamy R. Expanding transcatheter pulmonary valve therapies. JACC Cardiovasc Interv, 2020, 13(23): 2766-2768.
51. 中國醫師協會心血管內科醫師分會結構性心臟病學組, 亞洲心臟病學會, 國家放射與治療臨床醫學研究中心. 經導管肺動脈瓣置換術亞洲專家共識. 中國介入心臟病學雜志, 2023, 31(6): 404-412.Structural Heart Disease Group of Cardiovascular Physician Branch of Chinese Medical Doctor Association, Asian Society of Cardiology, National Clinical Research Center for Interventional Medicine. Asian expert consensus on transcatheter pulmonary valve replacement. Chin J Interv Cardiol, 2023, 31(6): 404-412.
52. Tannous P, Nugent A. Transcatheter pulmonary valve replacement in native and nonconduit right ventricle outflow tracts. J Thorac Cardiovasc Surg, 2021, 162(3): 967-970.

Chinese Journal of Clinical Thoracic and Cardiovascular Surgery

Advances in minimally invasive cardiac surgery for the treatment of valvular diseases

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content